NCT06400056View on ClinicalTrials.gov

Clinical and Laboratory Evaluation of Antifungal Resistance in Tinea Capitis

PHASE1Not yet recruitingINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

May 31, 2024

Primary Completion Date

April 30, 2025

Study Completion Date

May 31, 2025

Conditions

Fungal Resistance

Interventions

DRUG

Terbinafine

FDA approved

All Listed Sponsors

lead

Assiut University

OTHER

NCT06400056 - Clinical and Laboratory Evaluation of Antifungal Resistance in Tinea Capitis | Biotech Hunter | Biotech Hunter